Literature DB >> 16751357

Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury.

Kunihiko Izuishi1, Allan Tsung, Geetha Jeyabalan, Nathan D Critchlow, Jianhua Li, Kevin J Tracey, Richard A Demarco, Michael T Lotze, Mitchell P Fink, David A Geller, Timothy R Billiar.   

Abstract

High mobility group box 1 (HMGB1) is a NF released extracellularly as a late mediator of lethality in sepsis and as an early mediator of inflammation following injury. Here we demonstrate that in contrast to the proinflammatory role of HMGB1, preconditioning with HMGB1 results in protection following hepatic ischemia/reperfusion (I/R). Pretreatment of mice with HMGB1 significantly decreased liver damage after I/R. The protection observed in mice pretreated with HMGB1 was associated with a higher expression of IL-1R-associated kinase-M, a negative regulator of TLR4 signaling, compared with controls. We thus explored the possibility that HMGB1 preconditioning was mediated through TLR4 activation. HMGB1 preconditioning failed to provide protection in TLR4 mutant (C3H/HeJ) mice, but successfully reduced damage in TLR4 wild-type (C3H/HeOuj) mice. Our studies demonstrate that in contrast to the role of HMGB1 as an early mediator of inflammation and organ damage in hepatic I/R, HMGB1 preconditioning can be protective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751357     DOI: 10.4049/jimmunol.176.12.7154

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

Review 1.  Translational systems approaches to the biology of inflammation and healing.

Authors:  Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

Review 2.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

3.  Dear SIRS, the concept of "alarmins" makes a lot of sense!

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2007-10-17       Impact factor: 17.440

4.  Damage associated molecular pattern molecules.

Authors:  Michael T Lotze; Albert Deisseroth; Anna Rubartelli
Journal:  Clin Immunol       Date:  2007-04-30       Impact factor: 3.969

Review 5.  Danger signals in regulating the immune response to solid organ transplantation.

Authors:  Jamie L Todd; Scott M Palmer
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

6.  A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with Toll-like receptor 4 demonstrates inherent preconditioning behavior.

Authors:  Beatrice Rivière; Yekaterina Epshteyn; David Swigon; Yoram Vodovotz
Journal:  Math Biosci       Date:  2008-10-11       Impact factor: 2.144

Review 7.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

8.  Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.

Authors:  Marieke A D van Zoelen; Huan Yang; Sandrine Florquin; Joost C M Meijers; Shizuo Akira; Bernd Arnold; Peter P Nawroth; Angelika Bierhaus; Kevin J Tracey; Tom van der Poll
Journal:  Shock       Date:  2009-03       Impact factor: 3.454

9.  Extracellular BCL2 proteins are danger-associated molecular patterns that reduce tissue damage in murine models of ischemia-reperfusion injury.

Authors:  Akiko Iwata; Vicki Morgan-Stevenson; Barbara Schwartz; Li Liu; Joan Tupper; Xiaodong Zhu; John Harlan; Robert Winn
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

Review 10.  Pathophysiology of the systemic inflammatory response after major accidental trauma.

Authors:  Anne Craveiro Brøchner; Palle Toft
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-09-15       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.